- All sections
- C - Chemistry; metallurgy
- C07D - Heterocyclic compounds
- C07D 309/08 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
Patent holdings for IPC class C07D 309/08
Total number of patents in this class: 222
10-year publication summary
19
|
16
|
17
|
25
|
13
|
18
|
14
|
25
|
10
|
0
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Corsair Pharma, Inc. | 36 |
13 |
Bristol-myers Squibb Company | 4863 |
10 |
The General Hospital Corporation | 4650 |
6 |
The Broad Institute, Inc. | 1709 |
6 |
Enanta Pharmaceuticals, Inc. | 422 |
6 |
Global Blood Therapeutics, Inc. | 180 |
6 |
The Provost, Fellows, Foundation Scholars, and The Other Members of Board, of The College of The Holy and Undivided Trinity of Queen Elizabeth, Near Dublin | 160 |
6 |
The University of Queensland | 657 |
6 |
Massachusetts Institute of Technology | 9913 |
5 |
Modernatx, Inc. | 1206 |
5 |
Theravance Biopharma R&D IP, LLC | 517 |
5 |
Abbvie Inc. | 1782 |
4 |
Takeda Pharmaceutical Company Limited | 2943 |
4 |
Cytokinetics, Inc. | 268 |
4 |
Dongjin Semichem Co., Ltd. | 471 |
4 |
Xwpharma Ltd. | 59 |
4 |
Orsobio, Inc. | 12 |
4 |
BASF SE | 20432 |
3 |
Fuso Pharmaceutical Industries, Ltd. | 127 |
3 |
National University Corporation Gunma University | 303 |
3 |
Other owners | 115 |